PMGC HOLDINGS INC. Investment Income, Interest
PMGC HOLDINGS INC. (ELAB) reported Investment Income, Interest of $83.16 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- PMGC HOLDINGS INC. investment income, interest for the quarter ending 2026-06-30 was $83.16K, a 127.66% increase year-over-year.
- PMGC HOLDINGS INC. investment income, interest for the quarter ending 2026-03-31 was $62.92K, a 118.05% increase year-over-year.
- PMGC HOLDINGS INC. investment income, interest for the quarter ending 2025-12-31 was $28.24K, a 123.32% increase year-over-year.
- PMGC HOLDINGS INC. investment income, interest for the quarter ending 2025-09-30 was $24.41K, a 25590.53% increase year-over-year.
- PMGC HOLDINGS INC. investment income, interest for fiscal 2025 was $118.03K, a 815.60% increase from fiscal 2024.
- PMGC HOLDINGS INC. investment income, interest for fiscal 2024 was $12.89K, a 131.69% increase from fiscal 2023.
- PMGC HOLDINGS INC. investment income, interest for fiscal 2023 was $5.56K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $83.16K 10-Q · filed 2026-08-14 | $146.08K 10-Q · filed 2026-08-14 | $174.32K derived: sum of 3 quarters · filed 2026-08-14 | $198.73K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $62.92K 10-Q · filed 2026-05-15 | $91.16K derived: sum of 2 quarters · filed 2026-05-15 | $115.57K derived: sum of 3 quarters · filed 2026-05-15 | $152.09K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $28.24K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $52.65K derived: sum of 2 quarters · filed 2026-03-30 | $89.17K derived: sum of 3 quarters · filed 2026-08-14 | $118.03K 10-K · filed 2026-03-30 |
| 2025-09-30 | $24.41K 10-Q · filed 2025-11-14 | $60.93K derived: sum of 2 quarters · filed 2026-08-14 | $89.79K 10-Q · filed 2025-11-14 | $102.44K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $36.53K 10-Q · filed 2026-08-14 | $65.38K 10-Q · filed 2026-08-14 | $78.03K derived: sum of 3 quarters · filed 2026-08-14 | $78.12K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $28.86K 10-Q · filed 2026-05-15 | $41.50K derived: sum of 2 quarters · filed 2026-05-15 | $41.60K derived: sum of 3 quarters · filed 2026-05-15 | $41.66K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $12.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $12.74K derived: sum of 2 quarters · filed 2026-03-30 | $12.80K derived: sum of 3 quarters · filed 2026-03-30 | $12.89K 10-K · filed 2026-03-30 |
| 2024-09-30 | $95.00 10-Q · filed 2025-11-14 | $159.00 derived: sum of 2 quarters · filed 2025-11-14 | $245.00 10-Q · filed 2025-11-14 | $328.00 derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $64.00 10-Q · filed 2025-08-13 | $150.00 10-Q · filed 2025-08-13 | $233.00 derived: sum of 3 quarters · filed 2025-08-13 | $258.00 derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $86.00 10-Q · filed 2025-05-14 | $169.00 derived: sum of 2 quarters · filed 2025-05-14 | $194.00 derived: sum of 3 quarters · filed 2025-05-14 | $543.00 derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $83.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $108.00 derived: sum of 2 quarters · filed 2025-03-28 | $457.00 derived: sum of 3 quarters · filed 2025-03-28 | $5.56K 10-K · filed 2025-03-28 |
| 2023-09-30 | $25.00 10-Q · filed 2024-11-14 | $374.00 derived: sum of 2 quarters · filed 2024-11-14 | $5.48K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $349.00 10-Q · filed 2024-08-14 | $5.46K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $5.11K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |